Equiplas WNV

West Nile Virus Antibody, Equine Origin

The product license is conditional. Efficacy and potency test studies in progress.

950ML Single Dose

For use in horses only by a licensed veterinarian

The equine plasma contains no preservatives or additives. The donor used has been found free of hemolysins against 32 of the main antigens in blood groups A, C, D, K P, Q, U and negative for agglutinins in blood groups Aa and Qa. Donor has also tested negative for equine parvovirus, EIA, EVA, dourine, piroplasmosis, brucellosis and glanders.

INDICATION: This product can be administered to provide passive immunity as an aid in the control of disease associated with West Nile Virus in adult equidae.

DOSAGE: One dose of 2ml/kg is recommended IV.

ADMINISTRATION: The plasma should be kept frozen (-17° to -40° C) until required. It should be thawed using only warm water and then warmed to body temperature. Plasma can be damaged by thawing in very hot water or in microwaves. Administer directly from the bag by slow filtered intravenous infusion. Do not mix with other products. Caution should be taken to avoid volume overload. Complications are very infrequent but may include mild reactions such as tachypnea, tachycardia, and trembling. If these reactions become severe and also include sweating and excessive shaking, it is advisable to slow the rate of administration or to stop and restart in 5-10 minutes. If the symptoms recur or persist, discontinue administration.

Equiplas WNV Caution

This product is frozen immediately after collection and has not been processed by heating or treating with ionizing radiation, and may be capable of spreading disease, including hepatitis (Theiler’s Disease), which is possible with the administration of any blood product. In case of human exposure, contact a physician.

ADMINISTER THROUGH A FILTERED BLOOD ADMINISTRATION SET

Plasvacc USA Inc., 1535 Templeton Road, Templeton, CA 93465

(800) 654-9743

usmail@plasvaccusa.com

VLN/PCN: 360/3995.00

CPN: 1128013.2